{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19502544-pramlintide:v1","objectPathId":"pubmed-pmid-19502544-pramlintide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19502544-pramlintide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-19502544-pramlintide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-19502544-pramlintide-v1.md"},"story":{"slug":"pubmed-pmid-19502544-pramlintide","version":1,"domain":"Literature metadata","dateInSource":"2025-08-13","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["pramlintide"],"peptides":[{"slug":"pramlintide","url":"https://peptidescanner.com/peptides/pramlintide/"}]},"claims":[{"id":"headline","text":"Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes.","sourceIds":["pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde"]},{"id":"summary","text":"PubMed lists PMID 19502544 in Diabetes care as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-06-05 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde"]},{"id":"paragraph-1","text":"PubMed lists PMID 19502544 in Diabetes care as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-06-05 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde"]}],"sources":[{"id":"pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde","name":"PubMed","sourceClass":"A","title":"Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes. · retained source version 1:2025-08-13:current:ec4057673cded7f347da2ac2d1e5cdf7f0cabec9e02eff227a89b03cae22538a","url":"https://pubmed.ncbi.nlm.nih.gov/19502544/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ce806037f633e1650b3337fdd4244fa5ec29648ccfff6a877eb5fbb959eae3a1","tierARecordSha256":"de1a0c748d1f1a278c3fb0907639b96e6d139d564555a00affddc98d6d824eb0"},"integrity":{"algorithm":"sha256","contentSha256":"39a0586aa6511ac171bfb2c4fcf75365712988053a8cdfdd3adef577b8d15f18"}}